Company type
Developer of personalized cancer treatments.Funding rounds
Series B USD 27,400,000
USD 27,400,000 ( )
Funding to expand the availability of its CANScript service, which predicts personalised responses to cancer treatments. Part of the proceeds were used to cash out Series A backers Karnataka Information Technology Venture Capital Fund and India Innovation
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Sands Capital Ventures LLC | Led the round. | |||
Sequoia Capital India | Led the round. | |||
RA Capital Management | Initial investment. | |||
Accel Partners & Co Inc | Early and growth stage venture capital firm. | Follow-on investment. | ||
Tata Capital Innovations Fund | Follow-on investment. |
Investor | Profile | Country | |
---|---|---|---|
Accel Partners & Co Inc | Early and growth stage venture capital firm. |
Investment activity status
Active investor